Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy

Journal of Clinical Psychopharmacology

Volumn 29, Issue 3, 2009, Pages 304-306

  Sentissi, Othman ^a   Grouselle, Dominique ^b   Viala, Annie ^a   Bourdel, Marie Chantal ^a   Olié, Jean Pierre ^a,b   Epelbaum, Jacques ^b   Poirier, Marie F ^a,b  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHENONE; GHRELIN; LEPTIN; NEUROLEPTIC AGENT;

ADULT; BODY MASS; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOTHERAPY; PRIORITY JOURNAL; SCHIZOPHRENIA; WAIST CIRCUMFERENCE;

ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GHRELIN; HUMANS; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS;

EID: 67649271443     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181a390ed     Document Type: Letter

References (11)

1. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999;156:1686-1696.
2. Patel SB, Reams GP, Spear RM, et al. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep. 2008;10:131-137.
3. Ukkola O, Poykko SM, Antero Kesaniemi Y. Low plasma ghrelin concentration is an indicator of the metabolic syndrome. Ann Med. 2006;38:274-279.
4. Roerig JL, Steffen KJ, Mitchell JE, et al. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels. J Clin Psychopharmacol. 2008;28:21-26.
5. Sentissi O, Epelbaum J, Olié JP, et al. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review. Schizophr Bull. 2008;34:1189-1199.
6. Jin H, Meyer JM, Mudaliar S, et al. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res. 2008;10:70-85.
7. Tanaka K, Morinobu S, Ichimura M, et al. Decreased levels of ghrelin, cortisol, and fastingblood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1527-1532.
8. Yang J, Brown MS, Liang G, et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132:387-396.
9. Baptista T, Dávila A, El Fakih Y, et al. Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia. Int Clin Psychopharmacol. 2007;22:205-211.
10. Smith RC, Lindenmayer JP, Bark N, et al. Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients. Int J Neuropsychopharmacol. 2005;8:183-194.
11. Ingelsson E, Larson MG, Yin X, et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab. 2008;93:3149-3157.